• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - Protein
Tag:

Protein

Health

New Drug Reduces DNA Damage and Inflammation in Alzheimer’s Model

by Chief Editor July 8, 2026
written by Chief Editor

Researchers have identified a potential therapeutic pathway for Alzheimer’s disease by targeting DNA damage within brain neurons. A study published in FEBS Open Bio reports that the molecule KCL-286 successfully repairs neuronal DNA in mouse models, simultaneously reducing brain inflammation and abnormal immune activity associated with neurodegeneration.

How does KCL-286 target Alzheimer’s disease?

The drug KCL-286 functions as an agonist for the retinoic acid receptor-β (RARβ). According to the study published in FEBS Open Bio, activating this specific receptor triggers a biological pathway that encourages a protein complex to bind to DNA. This process promotes the expression of essential repair genes, effectively fixing damaged genetic material within neurons.

Jonathan Corcoran, a Professor of Neuroscience at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London, likens the process to road maintenance. “We think of the drug as repairing potholes in a road—once the damage is fixed, normal traffic can flow again and the system settles down,” Corcoran stated. By resetting the system through DNA repair, the researchers aim to mitigate the progression of neurodegenerative conditions.

Did you know?

Beyond its potential for Alzheimer’s treatment, researchers believe the principle of repairing neuronal DNA damage could have broader applications for nerve repair and various forms of neurodegeneration.

What is the current status of KCL-286 in clinical development?

KCL-286 has already completed phase I clinical trials, which established a favorable safety profile for human use. While the initial findings in mouse models are promising, Professor Corcoran noted that the next step requires securing appropriate funding to determine if the drug provides meaningful clinical benefits for human patients. “The opportunity is immediate, and the science is ready to advance,” Corcoran said.

How does DNA damage contribute to Alzheimer’s?

The accumulation of DNA damage in neurons may contribute to the development of Alzheimer’s disease. As neurons sustain genetic injury, they often trigger inflammatory responses and abnormal immune activity in the brain. The research by Hill et al. (2026) suggests that by correcting the underlying DNA instability, the brain’s immune system may return to a more stable, non-inflammatory state.

Pro Tip: Monitoring Neurodegeneration

Consult with a neurologist to discuss the latest clinical trial participation opportunities if you or a loved one are exploring emerging therapies.

Frequently Asked Questions

What is KCL-286?

KCL-286 is a first-in-class retinoic acid receptor-β (RARβ) agonist designed to promote the repair of DNA damage in neurons.

Has KCL-286 been tested on humans?

Yes, phase I clinical trials have been conducted, which confirmed that the drug has a favorable safety profile in humans.

What does the drug do to the brain?

According to research published in FEBS Open Bio, the drug activates genes responsible for DNA repair, which helps reduce neuroinflammation and abnormal immune activity in the brain.


Are you interested in the latest developments in neurodegenerative research? Subscribe to our newsletter for updates on clinical trials and breakthroughs in brain health.

July 8, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

New Compound Shows Promise for Pancreatic Cancer Treatment

by Chief Editor July 7, 2026
written by Chief Editor

Researchers have identified a new chemical compound, DE19725241, that shows potential in targeting the fat mass and obesity-associated protein (FTO) to treat pancreatic cancer. According to a study published in BIO Integration, the compound demonstrated selective antiproliferative activity in pancreatic cancer cell lines by binding to specific protein sites, offering a potential new scaffold for future cancer therapies.

How does FTO contribute to pancreatic cancer?

FTO functions as an epitranscriptomic regulator, a protein that influences how genetic information is expressed. Research led by Xu et al. (2026) utilized data from the Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) project to examine its role in oncology. The analysis revealed that FTO is frequently overexpressed in pancreatic tumors. Furthermore, high levels of this protein are statistically associated with poorer overall survival rates for patients, suggesting that FTO may play a significant role in tumor progression and immune regulation.

Did you know?
The researchers screened over 22 million compounds using active learning-assisted virtual screening to identify candidates capable of inhibiting FTO.

What is the significance of the compound DE19725241?

DE19725241 emerged as the lead candidate following extensive computational and laboratory testing. Scientists assessed the compound using binding pose metadynamics and molecular dynamics simulations to ensure it could effectively interact with FTO. The study found that DE19725241 shows favorable predicted interactions with three specific amino acid residues on the protein: ARG-96, TYR-108, and GLU-234. In in vitro testing, the compound exhibited moderate but selective activity against pancreatic cancer cells while sparing normal pancreatic epithelial cells, a key requirement for reducing potential systemic toxicity.

What is the significance of the compound DE19725241?

How do researchers validate new cancer drug candidates?

The development of DE19725241 followed a rigorous multi-stage validation process. After the initial virtual screening of millions of molecules, the team utilized MM/GBSA (Molecular Mechanics/Generalized Born Surface Area) calculations to estimate the binding free energy of the candidate. This computational work was then paired with laboratory experiments on three distinct pancreatic cancer cell lines. By comparing the response of these cancer cells against a normal pancreatic epithelial cell line, researchers were able to confirm the compound’s selectivity—a critical step in determining whether a molecule has the potential to progress toward clinical development.

Pro Tip: The role of epitranscriptomics

Epitranscriptomics involves the study of chemical modifications to RNA.

Good news in the fight against pancreatic cancer | Laura Indolfi

Frequently Asked Questions

What is FTO?

FTO stands for fat mass and obesity-associated protein. It is an enzyme that acts as an RNA demethylase, influencing gene expression by modifying RNA molecules.

Is DE19725241 currently available for patients?

No. DE19725241 is an early-stage research compound. It has only been tested in laboratory cell cultures, not in humans or clinical trials.

Why is pancreatic cancer difficult to treat?

Identifying regulators like FTO is part of a broader effort to find molecular targets that can disrupt cancer cell growth more effectively than traditional chemotherapy.


For more updates on oncology research and drug development, subscribe to our medical research newsletter or explore our archive of peer-reviewed summaries. Have questions about this study? Join the conversation in the comments below.

July 7, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

New Molecular Mechanism Linked to Inherited Heart Disease

by Chief Editor July 7, 2026
written by Chief Editor

Researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified a new molecular mechanism driving hypertrophic cardiomyopathy, the most common inherited heart disease. A study published in Nature Cardiovascular Research confirms that the targeted therapy mavacamten remains effective across various genetic mutations, potentially expanding treatment options for the estimated 95,230 patients living with the condition in Spain.

How does the newly identified mutation affect the heart?

Hypertrophic cardiomyopathy often stems from mutations in the MYBPC3 gene, which encodes cardiac myosin binding protein C. While many mutations lead to a drop in protein levels, the newly studied R502W variant functions differently. According to Laura Sen Martín, first author of the study, this mutation alters the protein’s ability to interact with other cardiac proteins rather than simply reducing its quantity.

The research team created a mouse model carrying the R502W variant to observe these effects. They found that the mutation specifically reduces the ability of cardiac myosin binding protein C to interact with myosin, the molecular motor responsible for heart contraction. This discovery provides a clearer understanding of the molecular chain reaction that causes the heart muscle to thicken and contract with excessive, potentially dangerous force.

Did you know?
Hypertrophic cardiomyopathy is a leading cause of sudden cardiac death in young people and athletes. It affects roughly 1 in every 250 to 500 people, according to data from the Spanish Heart Foundation and the CIBERCV.

Is mavacamten effective for all genetic variants?

The study suggests that mavacamten’s clinical utility is broader than previously understood. By testing the drug on both the R502W mouse model and models with a complete loss of cMyBP C, researchers observed that the drug successfully halted pathological heart muscle remodeling in both groups.

Is mavacamten effective for all genetic variants?

Dr. Jorge Alegre Cebollada, head of the CNIC Molecular Mechanics of the Cardiovascular System Group, notes that while the drug is transforming treatment, patient response has historically been variable. The findings indicate that this inconsistency is likely not due to the specific type of mutation a patient carries. In laboratory-grown human cardiac tissue, the drug consistently reduced excessive contractile force, suggesting a consistent therapeutic benefit across different molecular origins of the disease.

What does this mean for future patient care?

Because mavacamten modulates myosin activity directly, it addresses the “hypercontractility” that characterizes the disease regardless of the underlying genetic trigger. Researchers now aim to determine if early administration of the drug can improve therapeutic outcomes, a question that remains unresolved in the clinical setting.

Pro Tip:
When discussing treatment options, patients should consult their cardiologists about whether their specific genetic profile makes them candidates for targeted therapies like mavacamten.

Frequently Asked Questions

What is the primary cause of hypertrophic cardiomyopathy?

It is an inherited condition caused by mutations in genes that encode sarcomere proteins, the molecular machinery of the heart. The MYBPC3 gene is one of the most frequently involved.

CRY Research Day Dr Michael Papadakis Exercise in patients with Hypertrophic Cardiomyopathy

How does mavacamten work?

Mavacamten acts on myosin to modulate its activity. By doing so, it reduces the excessive force of heart muscle contractions, which helps prevent the abnormal thickening and rhythm disruptions associated with the disease.

Can this research help athletes at risk?

Because the disease is a leading cause of sudden cardiac death in athletes, identifying these molecular mechanisms early is vital. The new mouse model provides a tool for testing future targeted therapies that could eventually be used to intervene before life-threatening symptoms develop.


For more updates on cardiovascular research and breakthroughs in genetic medicine, subscribe to our weekly health newsletter. If you found this article informative, please share it with your professional network.

July 7, 2026 0 comments
0 FacebookTwitterPinterestEmail
Tech

How Adaptor Proteins Regulate Macrophages to Control Cancer

by Chief Editor July 7, 2026
written by Chief Editor

Adaptor proteins serve as critical molecular scaffolds that dictate whether tumor-associated macrophages (TAMs) attack cancer cells or promote tumor growth, according to a review published May 22, 2026, in Oncoscience. Researchers led by Khandu Wadhonkar and Mirza S. Baig at the Indian Institute of Technology Indore found that these proteins integrate complex signaling pathways, offering a new frontier for cancer immunotherapy by reprogramming immune cells rather than simply eliminating them.

How Adaptor Proteins Control Macrophage Behavior

Macrophage polarization within the tumor microenvironment is not a static process. According to the Oncoscience review, adaptor proteins act as the connectors between activated cell-surface receptors and the intracellular signaling pathways that trigger a cell’s response. Unlike enzymes, these proteins provide the structural scaffolding necessary for signaling complexes to assemble.

This assembly process determines whether a macrophage adopts an anti-tumor phenotype or a pro-tumor, immunosuppressive one. The researchers identified several key adaptor proteins involved in this regulation, including STING, MyD88, DAP12, TRIF, Gab2, TIRAP, RIAM, LAMTOR1, TRAF family proteins, CARD9, STAP, RACK1, TRIB1, and p62. These molecules influence major networks such as the NF-κB, PI3K-AKT, and mTOR pathways, which directly shape how immune cells interact with surrounding cancer cells.

Did you know?

Adaptor proteins often exhibit “functional plasticity.” For example, proteins like STING and MyD88 can switch roles, promoting anti-tumor activity in one environment while actively supporting tumor growth in another.

Why Adaptor Targeting Could Change Immunotherapy

The research team at IIT Indore suggests that targeting adaptor proteins allows for a more surgical approach: reprogramming existing macrophages. By selectively modifying these molecular scaffolds, clinicians might one day shift the tumor environment from supportive to hostile for cancer progression.

Why Adaptor Targeting Could Change Immunotherapy

Preclinical studies are currently investigating several ways to achieve this, including:

  • Small-molecule inhibitors to block specific pro-tumor signals.
  • Peptide-based therapies to disrupt protein-protein interactions.
  • Gene-silencing technologies to reduce the expression of tumor-supportive adaptors.
  • Targeted protein degradation to remove harmful signaling scaffolds entirely.

What Challenges Remain for Clinical Translation?

Translating these findings from the lab to the clinic remains difficult. The authors note that many adaptor proteins perform multiple functions throughout the body. Because their activity varies depending on the specific tissue type and the stage of the tumor, “off-target” effects are a significant concern.

Future research must prioritize precision. The review emphasizes that advanced techniques, such as single-cell transcriptomics, will be necessary to map exactly how these proteins behave in diverse clinical contexts. Without this level of detail, creating therapies that minimize damage to healthy immune function will remain the primary hurdle for researchers.

Pro Tip:

Keep an eye on single-cell sequencing developments.

Frequently Asked Questions

What are tumor-associated macrophages?

TAMs are immune cells found within tumors. They can either attack cancer cells or, if manipulated by the tumor, suppress the immune system and help the cancer grow and spread.

Delivering a Knockout to Cancer – KTVK Interview – Gateway for Cancer Research

Why are adaptor proteins better targets than enzymes?

Adaptor proteins act as central “hubs” for signaling. By targeting them, researchers can potentially control multiple downstream pathways at once, offering a more comprehensive way to reprogram immune cell behavior.

Are there FDA-approved drugs targeting these proteins?

Not yet. The research mentioned in the Oncoscience review is currently focused on preclinical studies and experimental approaches rather than established clinical treatments.


Are you interested in the latest advancements in cancer biology? Subscribe to our newsletter for updates on emerging research and the future of immunotherapy.

July 7, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Ditch Protein Powder for This Ancestral Superfood

by Chief Editor July 7, 2026
written by Chief Editor

Consumers are increasingly replacing traditional whey and plant-based protein powders with bone broth-derived collagen to support joint mobility and gut health. This shift toward “ancestral superfoods” focuses on nutrient-dense ingredients, such as grass-fed beef bones, to provide protein and amino acids without the fillers often found in processed supplements.

Why are consumers shifting from whey to bone broth collagen?

The supplement market is seeing a move away from dairy-based whey and plant proteins toward ancestral nutrition. According to reporting by New York Post Commerce Writer Miska Salemann, many users are seeking out bone broth-derived formulas as an alternative to more processed options.

Brands like Paleo Valley market their bone broth as an "ancestral superfood," utilizing grass-fed and pasture-raised beef bones. Unlike many standard protein powders, these formulas are often gluten-free, dairy-free, and contain no fillers.

Did you know? Bone broth has been used for centuries for its purported health benefits, long before the modern rise of synthetic protein powders.

What health benefits do users report from bone broth supplements?

User feedback suggests that the benefits of bone broth collagen extend beyond simple protein intake. Many consumers report significant improvements in physical mobility and aesthetic health.

What health benefits do users report from bone broth supplements?

Joint health appears to be a major factor in the product’s popularity. One Amazon reviewer stated that the product helped with “decreased stiffness” and eliminated “inflammation in the knees” and “painful feet.” The same user reported being able to get up from chairs and couches without pain after suffering from severe knee issues for over a year.

Beyond joint relief, users have noted improvements in several other areas:

  • Skin, Hair, and Nails: Multiple users reported visible improvements in these areas.
  • Digestive Health: Some consumers claim the formula is gentler on the digestive system compared to processed protein powders.

“When I say I am amazed, that’s an understatement. To be able to get up from chairs, couches, etc., with no pain is a blessing.” — Amazon User Review

How does the “ancestral” supplement trend impact future nutrition?

Pro tip: Bone broth collagen is highly versatile. It can be easily mixed into smoothies, morning coffees, or even used in baked goods.

Product Availability and Varieties

For those looking to trial these ancestral formulas, Paleo Valley offers several flavor profiles on Amazon, including plain, chocolate, vanilla, and salted caramel. The product is priced at approximately $53, with occasional discounts making a month-long supply more accessible.

Paleovalley Whey Protein & Bone Broth Review – The Best Protein?

Frequently Asked Questions

Is bone broth collagen better than whey protein?

While whey is a common protein source, users reported that bone broth collagen may be gentler on the digestive system and more effective for joint and skin health.

What makes Paleo Valley bone broth different?

According to the brand, the formula is derived from grass-fed, pasture-raised beef bones and is gluten-free, dairy-free, and free of fillers.

Can I use bone broth powder in coffee?

Yes, the powder is designed to mix easily into liquids like coffee and smoothies.

What are your thoughts on the shift toward ancestral nutrition? Let us know in the comments below or subscribe to our newsletter for more wellness trends.

July 7, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

New Engineered Scaffold Restores Skull Growth in Craniosynostosis Models

by Chief Editor July 5, 2026
written by Chief Editor

Researchers have developed a triphasic biomaterial scaffold that successfully restores the cranial suture stem cell niche in cases of craniosynostosis. According to a study published in Bone Research on May 28, 2026, the scaffold—engineered from poly(L-lactic acid)—prevents premature skull bone fusion by maintaining essential skeletal stem cells, offering a potential alternative to invasive surgical procedures for children affected by the condition.

How Does the Triphasic Scaffold Work?

The scaffold functions by mimicking the natural “bone-suture-bone” architecture of the skull. Led by Yuji Mishina of the University of Michigan and W. Benton Swanson of Harvard University, the team designed the device with three distinct, interconnected compartments. Each compartment features varying pore sizes to control cell behavior.

The central compartment utilizes small pores specifically to preserve the properties of skeletal stem cells. Meanwhile, the larger pores in the surrounding compartments are engineered to promote vascularization and new bone formation. According to the study, this spatial organization allows the scaffold to act as a reservoir for stem cells while simultaneously encouraging the growth of necessary surrounding tissue.

Did you know?

Craniosynostosis affects approximately one in every 2,500 births. It occurs when the fibrous joints between skull bones fuse prematurely, often requiring multiple surgeries to correct the resulting head shape and intracranial pressure.

Can the Scaffold Withstand Biological Pressure?

A primary challenge in treating craniosynostosis is the body’s tendency to trigger abnormal bone growth, or ossification, even after surgical intervention. To test the durability of their design, researchers exposed the scaffold to excessive bone morphogenetic protein activity, which is a common biological driver of suture fusion.

The study found that the central compartment of the scaffold successfully resisted this pressure. By maintaining a non-bony microenvironment, the device prevented the stem cells from prematurely turning into bone. This suggests the scaffold can effectively counteract the biological signals that usually cause post-surgical re-fusion.

Future Trends in Craniofacial Regeneration

The success of the triphasic scaffold in mouse models of midline craniosynostosis points toward a shift in how researchers might approach pediatric skull defects. Current standard treatments rely on mechanical reopening of the skull, which carries a risk of the sutures fusing again. By contrast, the regenerative approach seeks to rebuild the biological niche itself.

According to W. Benton Swanson, the principles of rational biomaterial design demonstrated in this research may eventually extend beyond craniosynostosis. The ability to control stem cell fate through structural engineering provides a framework that could be applied to other skeletal disorders and developmental conditions where tissue loss or abnormal fusion is a factor.

Frequently Asked Questions

What is the main advantage of this new scaffold?

Unlike traditional surgery that simply reshapes the skull, this scaffold regenerates the biological stem cell niche, which helps maintain normal growth patterns and prevents the sutures from fusing again.

What material is the scaffold made of?

The scaffold is made from poly(L-lactic acid), a biodegradable, FDA-approved biomaterial already used in various medical applications.

Has this been tested in humans?

No. As of the May 2026 report in Bone Research, the findings are based on successful experiments in mouse models that closely resemble human nonsyndromic craniosynostosis.

Explore More

Are you interested in the latest developments in regenerative medicine? Subscribe to our monthly research newsletter to stay updated on breakthrough biomaterial studies and pediatric health innovations.

July 5, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

New Experimental Drug Protects Nerve Cells From ALS Damage

by Chief Editor July 3, 2026
written by Chief Editor

University of Arizona researchers have developed an experimental drug, XL20, that shows potential to protect nerve cells from damage associated with amyotrophic lateral sclerosis (ALS). According to a study published in Nature Aging, the drug targets a specific region of the TDP-43 protein to prevent toxic clumping, a process that contributes to neurodegeneration in ALS and other age-related conditions.

How does the experimental drug XL20 work?

The drug XL20 functions by latching onto a specific, conserved region of the TDP-43 protein. Research led by Xinglong Wang, a professor at the R. Ken Coit College of Pharmacy, identified this region as a primary driver of protein toxicity. By targeting this area, the drug prevents the protein from forming harmful clumps inside nerve cells without interfering with its normal, healthy functions. According to the study, XL20 is capable of crossing the blood-brain barrier, a critical requirement for treating neurological conditions.

Did you know?
The protein TDP-43 is essential for normal cell function. In ALS patients, it drifts out of its proper location in the brain’s nerve cells, forming toxic clumps that are now used to confirm an ALS diagnosis during autopsies.

Why has ALS been historically difficult to treat?

ALS is challenging to address because symptoms often appear only after significant nerve cell damage has already occurred. According to Wang, the first signs—such as limb weakness—frequently mask the fact that the disease has been progressing. While nearly all ALS cases involve TDP-43 pathology, fewer than one in 10 cases are inherited. The remaining cases arise sporadically, making it difficult to predict or treat the disease before the onset of severe motor neuron loss.

How does this research impact other neurodegenerative diseases?

The implications of the XL20 study extend beyond ALS. The same TDP-43 abnormality is a hallmark of limbic-predominant age-related TDP-43 encephalopathy (LATE), a dementia affecting roughly one in three people over the age of 80. Furthermore, TDP-43 pathology is present in more than half of all Alzheimer’s disease patients, where it is linked to accelerated cognitive decline. Wang suggests that if this targeted approach proves effective in future clinical development, it could offer a therapeutic avenue for a much broader range of neurodegenerative conditions.

Comparison: Current Treatments vs. Experimental Approaches

Treatment Type Key Characteristic
Current FDA-approved drugs Provide only modest benefits for patients.
XL20 (Experimental) Directly targets TDP-43 clumping to protect nerve cells.

Frequently Asked Questions

What is the status of XL20?

XL20 has shown success in mouse models, where it extended median survival and reduced muscle weakness. It has also been tested on human motor neurons in lab settings, where it reversed some of the same damage. It is currently a candidate for future clinical development.

Mayo Clinic ALS Study

Is the damage caused by TDP-43 reversible?

In laboratory testing on human motor neurons, the experimental drug XL20 successfully reversed some of the damage caused by TDP-43, according to the research team.

Does this drug affect healthy protein function?

No. According to Ju Gao and Xinglong Wang, the research team spent a decade confirming that deleting the target region—and using the drug to block it—does not disturb the protein’s normal, necessary functions within the cell.

Pro Tip:
Early intervention remains the gold standard for neurodegenerative diseases. As research into drugs like XL20 continues, stay informed on clinical trial registries to track the progress of potential breakthroughs for ALS and related dementias.

Are you interested in the latest developments in neurodegenerative research? Subscribe to our newsletter for updates on breakthroughs in ALS and dementia treatments.

July 3, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Nutrient Deficiencies Lurk in Plant-Based Diets: New Dutch Study Reveals Alarming Truth

by Chief Editor July 3, 2026
written by Chief Editor

What Happens When You Swap Animal Proteins for Plant-Based Alternatives?

A new Dutch study published in Nutrients reveals that shifting to plant-based diets can lower intake of critical nutrients like protein, vitamin B12, and calcium, particularly for older adults and adolescents. The research, conducted by a team including J. de Vries and colleagues, analyzed data from 3,570 participants across age groups to model the effects of replacing animal-based foods with plant-based alternatives.

According to the study, even a partial shift—replacing meat, fish, and dairy with plant-based products—can lead to nutrient shortfalls. For example, older adults (71-79 years) saw a significant drop in protein intake, falling below recommendations from the European Society for Clinical Nutrition and Metabolism (ESPEN). This highlights the need for strategic dietary planning when adopting plant-based eating.

Why Older Adults and Teens Are Most at Risk

Older adults faced the sharpest declines in essential nutrients, including methionine, a sulfur amino acid critical for muscle and bone health. The study found that even in a “nutritionally conscious” scenario—where plant-based substitutes were chosen for their nutritional value—older adults still struggled to meet recommended levels. Adolescents also experienced gaps, particularly in protein and vitamin B12, which are vital for growth and development.

“The results underscore that plant-based diets require careful structuring to avoid deficiencies,” said Dr. J. de Vries, lead author of the study. “Without targeted guidance, vulnerable groups like seniors and teens may face long-term health risks.”

How Do Different Age Groups Fare in the Study?

The research divided participants into two dietary scenarios: one where plant-based swaps prioritized nutritional quality, and another using widely available but less nutrient-dense alternatives. Both scenarios showed declines in protein and key vitamins, but the less conscious approach exacerbated deficiencies.

For instance, females over 18 years old in the nutritionally conscious scenario had protein intake below recommendations, while males aged 31-50 also fell short. Vitamin D, already lacking in the original diets, remained inadequate after substitution. Meanwhile, vitamin E increased due to higher plant-based intake, offering a silver lining.

What Role Do Fortified Foods Play in Bridging Gaps?

The study emphasizes the potential of fortified foods and tailored dietary advice to mitigate nutrient losses. For example, calcium and vitamin D deficiencies could be addressed through fortified plant milks or supplements. Similarly, iodine and selenium, which declined in both scenarios, might be replenished via seaweed or fortified salts.

“Fortification and personalized guidance are not just helpful—they’re essential,” said Dr. C.M. Singh-Povel, a co-author. “Without them, the health benefits of plant-based diets could be overshadowed by nutritional gaps.”

What Are the Long-Term Implications for Public Health?

The findings have significant implications for public health policies, especially as plant-based eating gains traction. The Dutch government has already begun exploring ways to integrate nutrient-rich plant-based options into school meals and senior nutrition programs. Similar initiatives are underway in other European countries, reflecting a growing awareness of the need for balance.

“This study isn’t just about individual choices—it’s about systemic support,” said Dr. L.A.A.C.M. Oudhuis, a researcher involved in the project. “Policymakers, healthcare providers, and food manufacturers must collaborate to ensure plant-based diets are both sustainable and nutritious.”

Did You Know?

Plant-based diets can reduce greenhouse gas emissions by up to 50%, but the study shows this environmental benefit must be paired with nutritional safeguards. For example, legumes are a good protein source, but they lack certain amino acids found in animal products.

New Study: Plant-Based Dieters Catch Less COVID

How Can Individuals Adapt to a Plant-Based Lifestyle?

For those considering a plant-based transition, the study offers actionable steps. Prioritize protein-rich foods like lentils, quinoa, and tofu, and pair them with vitamin C-rich fruits to enhance iron absorption. Including fortified foods and considering supplements for B12 and D can also help.

“It’s not about perfection—it’s about intentionality,” said Dr. P. de Vos. “Small, mindful changes can make a big difference in maintaining nutritional balance.”

Pro Tips for a Balanced Plant-Based Diet

  • Combine legumes with whole grains to create complete protein profiles.
  • Use fortified plant milks to boost calcium and vitamin D intake.
  • Include seaweed or iodized salt to replenish iodine.

What’s Next for Plant-Based Nutrition Research?

The study calls for further research into nutrient bioavailability and long-term health outcomes. For instance, while plant-based diets may lower chronic disease risk, their impact on bone health or immune function remains underexplored. Researchers also aim to refine dietary guidelines to better suit diverse populations.

“We need more data on how real-world eating patterns affect nutrition,” said Dr. R.

FAQ: Common Questions About Plant-Based Diets

Why do plant-based diets sometimes lack essential nutrients?

Many plant-based foods are lower in protein, vitamin B12, and certain minerals like calcium and iron compared to animal products. Without careful planning, deficiencies can occur.

How can I ensure adequate protein on a plant-based diet?

Include a variety of protein sources like beans, nuts, seeds, and whole grains. Combining different plant foods (e.g., rice and beans) ensures all essential amino acids are consumed.

July 3, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

The Ultimate Low-Cal Dessert for Longevity, Gut Health, and Joint Relief

by Chief Editor June 28, 2026
written by Chief Editor

Gelatin, a protein derived from animal collagen, is gaining traction as a functional food ingredient due to its potential to support joint health, skin elasticity, and digestive function. According to the National Institutes of Health, supplemental gelatin is considered safe at doses between 5 and 15 grams daily for up to six months.

How Does Gelatin Support Joint and Skin Health?

Gelatin functions as a concentrated source of collagen, the primary structural protein in the human body. As people age, natural collagen production declines, often leading to reduced skin elasticity and joint discomfort. By providing the body with amino acids, gelatin may help maintain the density of cartilage and connective tissues. Research suggests that these proteins can act as building blocks for structural repair, potentially mitigating the wear and tear on joints that contributes to chronic pain.

Did you know? A single tablespoon of gelatin contains approximately 6 grams of protein and only 10 calories, making it a nutrient-dense addition to soups, broths, and desserts.

What Role Does Gelatin Play in Gut Health?

Emerging research points to gelatin’s potential to protect the intestinal lining. Glutamic acid, a key amino acid found in gelatin, can protect the intestinal wall from damage and prevent leaky gut. While further research is needed in humans, studies on animal models have demonstrated improved intestinal wall health following gelatin consumption.

What Role Does Gelatin Play in Gut Health?

Comparing Gelatin Supplements to Whole Foods

Consumers often choose between processed gelatin desserts and pure collagen supplements. While the National Institutes of Health (NIH) provides safety guidelines for supplementation, it is important to distinguish between commercial products.

Nutritional Profile Comparison

  • Gelatin: High in glycine and glutamic acid; supports connective tissue.
  • Commercial Jell-O: Contains gelatin.

Future Trends in Collagen-Based Nutrition

Expect to see more collagen-infused snacks—ranging from gummy candies to fortified sauces—that target aging populations interested in bone density and joint mobility.

Why We Start with National Institutes of Health Research, Not Marketing Trends
Pro Tip: To maximize the benefits of gelatin, incorporate it into savory dishes like bone broths or stews.

Frequently Asked Questions

Is the “Jell-O diet” a safe way to lose weight?

No. The “Jell-O diet” of nothing but gelatin, vinegar and baking soda is a fake AI diet that causes stomach issues.

How much gelatin is considered safe to consume?

The National Institutes of Health suggests that consuming between 5 and 15 grams of gelatin per day for up to six months is safest.

Can gelatin help with type 2 diabetes?

Glycine, an amino acid found in gelatin, has been shown to help manage blood sugar levels in those with type 2 diabetes, as well as reduce inflammation.


Have you experimented with adding collagen-rich foods like bone broth or gelatin to your daily routine? Share your experiences in the comments below or subscribe to our health newsletter for more evidence-based nutrition insights.

June 28, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

How to Lose 25kg in 24 Weeks: 3 Simple Rules from a Fitness Coach

by Chief Editor June 28, 2026
written by Chief Editor

Zee Ali, a 46-year-old health and fitness expert, lost 25 kg in 24 weeks by prioritizing high protein intake, consistent sleep, and hydration over restrictive dieting. According to his June 22 Instagram post, Ali transitioned from 101 kg to 76 kg by consuming 180–200 grams of protein daily and maintaining a strict 10:30 pm bedtime to regulate hunger and metabolic health.

Why is protein-centric dieting replacing calorie restriction?

The shift toward high-protein nutrition marks a departure from traditional low-calorie “starvation” diets. Ali reported that even while eating less food overall, he maintained a protein intake of 180–200 grams per day. He stated this specific range helped preserve muscle mass, reduce cravings, and keep his metabolism high during his weight loss.

Why is protein-centric dieting replacing calorie restriction?

This method addresses a common failure in weight management: the loss of lean muscle tissue. When individuals cut calories without sufficient protein, the body often burns muscle for energy. By focusing on protein, Ali noted he was able to burn belly fat faster while becoming “fitter, leaner, and stronger.”

Pro Tip: When increasing protein, focus on whole sources like lean meats, legumes, or Greek yogurt to ensure you are also getting essential micronutrients.

How do sleep and hydration influence metabolic success?

Beyond macronutrients, lifestyle pillars like sleep hygiene and hydration are emerging as critical components of weight management. Ali identified sleep and water as his “secret weapons.” He adhered to a 10:30 pm bedtime every night and consumed 3–4 liters of water daily.

Ali linked these habits directly to hunger control. He explained that increased sleep leads to higher energy levels, while consistent hydration helps reduce hunger signals. This suggests that weight loss may be as much about hormonal regulation through rest as it is about food consumption.

Did you know? Dehydration can often be mistaken for hunger by the brain, leading to unnecessary calorie consumption.

Can routine prevent the cycle of junk food cravings?

Consistency through planning appears to be a primary driver for long-term success. Ali noted that “no plan means no control,” advocating for the use of pen and paper to schedule gym sessions, walks, and sleep in advance. He argued that a pre-planned routine prevents life’s distractions from derailing fitness goals.

Healthy Diet Plan for Weight Loss | High Protein Meals

His approach targets the psychological aspect of dieting. Ali observed that a lack of satiety leads to cravings, which subsequently leads to junk food consumption and a lack of results. By managing hunger through protein and managing time through routine, he bypassed the common “yo-yo” dieting cycle.

Comparison of Weight Loss Approaches

Feature Traditional Restrictive Diet Ali’s Sustainable Method
Primary Focus Calorie Deficit/Starvation Protein & Lifestyle Habits
Hunger Management Often ignored/suppressed Managed via protein & water
Sustainability Low (leads to cravings) High (built on routine)

Frequently Asked Questions

How much weight did Zee Ali lose?
Ali lost 25 kg, dropping from 101 kg to 76 kg.

Comparison of Weight Loss Approaches

How long did the transformation take?
The transformation was completed over a period of 24 weeks.

What was his daily protein target?
He maintained a daily protein intake of 180–200 grams.

What time did he go to bed?
He went to bed by 10:30 pm every night to ensure adequate sleep.

Note: This report is based on user-generated content from social media. Individual nutritional needs vary based on age, weight, and health status. Consult a healthcare professional before making significant dietary changes.

Want more health and fitness insights?

Subscribe to our newsletter or leave a comment below with your own weight loss journey!

June 28, 2026 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • The 2002 Surfing Game With Mind-Blowing Water Graphics

    July 10, 2026
  • 66-Year-Old Nandlal Sharma Completes Epic 2,821 km Cycling Journey

    July 10, 2026
  • New AI System Detects Previously Unseen Earthquake Signals

    July 10, 2026
  • Nicușor Dan’s Move: What Romania’s President Plans for Party Talks at Cotroceni Palace

    July 10, 2026
  • Tour de France: Merlier Wins Sprint in Bordeaux

    July 10, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

© 2026 Newsy Today. All rights reserved.
For contact, advertising, copyright, issues email: [email protected]


Back To Top

For contact, advertising, copyright, issues email: [email protected]

Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World